Article Contents ::
- 1 Details Descriptions About :: Cystic Fibrosis
- 2 In cystic fibrosis, dysfunction of the exocrine glands affects multiple organ systems. The disorder is characterized by chronic airway infection leading to bronchiectasis, bronchiolectasis, exocrine pancreatic insufficiency, intestinal dysfunction, abnormal sweat gland function, and reproductive dysfunction. Cystic fibrosis is accompanied by many complications and has a median survival rate of 31 years. The disease affects males and females and is the most common fatal genetic disease in children of European ancestry. There are more than 21,000 patients with cystic fibrosis in the United States.
- 3 Causes for Cystic Fibrosis
- 4 Pathophysiology Cystic Fibrosis
- 5 Signs and symptoms Cystic Fibrosis
- 6 Diagnostic Lab Test results
- 7 Treatment for Cystic Fibrosis
- 8 Disclaimer ::
- 9 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details Descriptions About :: Cystic Fibrosis
In cystic fibrosis, dysfunction of the exocrine glands affects multiple organ systems. The disorder is characterized by chronic airway infection leading to bronchiectasis, bronchiolectasis, exocrine pancreatic insufficiency, intestinal dysfunction, abnormal sweat gland function, and reproductive dysfunction. Cystic fibrosis is accompanied by many complications and has a median survival rate of 31 years. The disease affects males and females and is the most common fatal genetic disease in children of European ancestry. There are more than 21,000 patients with cystic fibrosis in the United States.
Causes for Cystic Fibrosis
Causes Inherited as an autosomal recessive trait, the responsible gene, on chromosome 7q, encodes a membrane-associated protein called the cystic fibrosis transmembrane regulator (CFTR). The exact function of CFTR remains unknown, but it appears to help regulate chloride and sodium transport across epithelial membranes.
Pathophysiology Cystic Fibrosis
Pathophysiology Most cases of cystic fibrosis arise from the mutation that affects the genetic coding for a single amino acid, resulting in a protein (CFTR) that doesn’t function properly. CFTR resembles other transmembrane transport proteins, but it lacks the phenylalanine in the protein produced by normal genes. This regulator interferes with chloride channels regulated by cyclic adenosine monophosphate, and with other ions, by preventing adenosine triphosphate from binding to the protein or by interfering with activation by protein kinase. The mutation affects volume-absorbing epithelia (in the airways and intestines), salt-absorbing epithelia (in sweat ducts), and volume-secretory epithelia (in the pancreas). Lack of phenylalanine leads to dehydration, which increases the viscosity of mucous gland secretions and leads to obstruction of glandular ducts. Cystic fibrosis has a variable effect on electrolyte and water transport.
Signs and symptoms Cystic Fibrosis
Signs and symptoms Thick secretions and dehydration Chronic airway infections Dyspnea and paroxysmal cough Failure to thrive: poor weight gain, poor growth, distended abdomen, thin extremities, and sallow skin with poor turgor Crackles and wheezes Retention of bicarbonate and water Obstruction of small and large intestines; biliary cirrhosis Fatal shock and arrhythmias Clotting problems, retarded bone growth, and delayed sexual development
Diagnostic Lab Test results
Diagnostic test results The Cystic Fibrosis Foundation has developed certain criteria for definitive diagnosis: Two sweat tests (to detect elevated sodium chloride levels) using a pilocarpine solution (a sweat inducer) and presence of an obstructive pulmonary disease, confirmed pancreatic insufficiency or failure to thrive, or a family history of cystic fibrosis. Age Alert The sweat test may be inaccurate in very young infants because they may not produce enough sweat for a valid test. The test may need to be repeated. Chest X-rays show an enlarged chest cavity and decreased lung markings, reflecting destruction of lung tissue. Stool specimen analysis indicates the absence of trypsin, suggesting pancreatic insufficiency. These test results may support the diagnosis: DNA testing can locate the presence of the Delta F 508 deletion (found in about 70% of patients with cystic fibrosis, although the disease can cause more than 100 other mutations). It allows prenatal diagnosis in families with a previously affected child. Pulmonary function tests reveal decreased vital capacity, elevated residual volume due to air entrapments, and decreased forced expiratory volume in 1 second. Liver enzyme tests reveal hepatic insufficiency. Sputum culture reveals organisms that cystic fibrosis patients typically and chronically colonize, such as Staphylococcus and Pseudomonas. Serum albumin measurement helps assess nutritional status. Electrolyte analysis assesses hydration status.
Treatment for Cystic Fibrosis
Treatment Diet with increased fat and sodium Salt supplements Pancreatic enzyme replacement Breathing exercises, chest percussion, and postural drainage Inhaled beta-adrenergic agonists Antibiotics such as azithromycin Sodium-channel blocker Uridine triphosphate Transplantation of heart or lungs Dornase alfa Gene therapy Anti-inflammatory agents such as ibuprofen Positive expiratory pressure devices Flutter valves High-frequency chest compression vest